ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
FCUV
Focus Universal Inc.
There isn't enough reported data to score FCUV yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
FCUV Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
FCUV's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
FCUV PE Valuation
FCUV has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
FCUV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect FCUV's losses to grow, with revenue declining.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
FCUV has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus FCUV down 243%.
FCUV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$32.40 | -$9.73 |
| Q2 2025 | -$18.00 | +$16.67 |
| Q1 2025 | -$18.00 | +$16.67 |
| Q4 2024 | -$19.20 | +$15.47 |
| Q3 2024 | -$22.67 | +$5.33 |
| Q2 2024 | -$34.67 | -$5.34 |
| Q1 2024 | -$34.67 | -$8.00 |
| Q4 2023 | -$34.67 | -$5.34 |
FCUV lost $32.40 per share over the past year, a bigger loss than the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over FCUV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
FCUV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $802.4K | +2697% |
| Q2 2026 | $675.2K | +1811% |
| Q1 2026 | $48K | -75% |
| Q4 2025 | $749 | -99% |
| Q3 2025 | $28.7K | -61% |
| Q2 2025 | $35.3K | +79% |
| Q1 2025 | $190.3K | -13% |
| Q4 2024 | $133.2K | -53% |
FCUV's revenue is growing: $802,428 last quarter, up 2697% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -144% | +3970 points |
| Q2 2026 | -230% | +4137 points |
| Q1 2026 | -2651% | -1983 points |
| Q4 2025 | -119974% | -118466 points |
| Q3 2025 | -4114% | -1761 points |
| Q2 2025 | -4367% | +2615 points |
| Q1 2025 | -668% | -66 points |
| Q4 2024 | -1508% | -934 points |
FCUV has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
FCUV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$853.8K | +$209.3K |
| Q2 2026 | -$7.4M | -$6M |
| Q1 2026 | -$1.1M | +$94.6K |
| Q4 2025 | -$1.4M | -$391.2K |
| Q3 2025 | -$1.1M | +$877.4K |
| Q2 2025 | -$1.4M | -$595.4K |
| Q1 2025 | -$1.2M | -$346.3K |
| Q4 2024 | -$1M | -$77.7K |
FCUV has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over FCUV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
FCUV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +36% | +206K shares |
| 1 year | +309% | +582K shares |
| 3 years | +373% | +607K shares |
| 5 years | +401% | +617K shares |
| Available history | +402% | +617K shares |
FCUV has 770,216 diluted shares, up 309% from a year ago, despite $598,857 in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $199,526 |
| Q1 2026 | $154,617 |
| Q4 2025 | $244,714 |
| Q3 2025 | $75,838 |
| Q2 2025 | $29,262 |
| Q1 2025 | $144,575 |
| Q4 2024 | $669,906 |
FCUV spent $598,857 buying back its own shares over the past year, down 35% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FCUV Net Leverage
FCUV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
FCUV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 2.8 | Oversold |
FCUV's weekly RSI is 39 (neutral) and its Stochastic is 3 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
FCUV PE vs Technology Sector
FCUV has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over FCUV on trend strength, trading above more of its moving averages.
FCUV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.64 | 18% below |
| 20 week MA | $5.49 | 45% below |
| 50 week MA | $18.1 | 83% below |
| 100 week MA | $88.7 | 97% below |
| 200 week MA | $298.3 | 99% below |
FCUV is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over FCUV on returns for 2026, with the stronger performance.
FCUV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,333.3 | $813.3 | -39% |
| 2021 | $813.3 | $2,690.7 | +231% |
| 2022 | $2,690.7 | $1,640.0 | -39% |
| 2023 | $1,640.0 | $584.0 | -64% |
| 2024 | $584.0 | $150.0 | -74% |
| 2025 | $150.0 | $44.8 | -70% |
| 2026 YTD | $44.8 | $3.00 | -93% |
FCUV has finished four years in a row lower, and it's down 93% so far in 2026.